These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 22038924)

  • 1. Chemokines: established and novel targets in atherosclerosis.
    Koenen RR; Weber C
    EMBO Mol Med; 2011 Dec; 3(12):713-25. PubMed ID: 22038924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokines: inflammatory mediators of atherosclerosis.
    Liehn EA; Zernecke A; Postea O; Weber C
    Arch Physiol Biochem; 2006; 112(4-5):229-38. PubMed ID: 17178596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines and atherosclerotic plaque progression: towards therapeutic targeting?
    Kraaijeveld AO; de Jager SC; van Berkel TJ; Biessen EA; Jukema JW
    Curr Pharm Des; 2007; 13(10):1039-52. PubMed ID: 17430167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherosclerosis: current pathogenesis and therapeutic options.
    Weber C; Noels H
    Nat Med; 2011 Nov; 17(11):1410-22. PubMed ID: 22064431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring immune checkpoints as potential therapeutic targets in atherosclerosis.
    Kusters PJH; Lutgens E; Seijkens TTP
    Cardiovasc Res; 2018 Mar; 114(3):368-377. PubMed ID: 29309533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokines in atherosclerosis: proceedings resumed.
    Zernecke A; Weber C
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):742-50. PubMed ID: 24436368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokines and atherosclerosis.
    Sheikine Y; Hansson GK
    Ann Med; 2004; 36(2):98-118. PubMed ID: 15119830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CC chemokine receptors and chronic inflammation--therapeutic opportunities and pharmacological challenges.
    White GE; Iqbal AJ; Greaves DR
    Pharmacol Rev; 2013 Jan; 65(1):47-89. PubMed ID: 23300131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemokine system as a therapeutic target in autoimmune thyroid diseases: a focus on the interferon-γ inducible chemokines and their receptor.
    Rotondi M; Chiovato L
    Curr Pharm Des; 2011; 17(29):3202-16. PubMed ID: 21864266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines as pharmacological targets.
    Galliera E; Corsi MM; Bonecchi R; Locati M; Mantovani A
    Mini Rev Med Chem; 2008 Jun; 8(7):638-46. PubMed ID: 18537719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-faceted strategies to combat disease by interference with the chemokine system.
    Johnson Z; Schwarz M; Power CA; Wells TN; Proudfoot AE
    Trends Immunol; 2005 May; 26(5):268-74. PubMed ID: 15866240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic targeting of chemokine interactions in atherosclerosis.
    Koenen RR; Weber C
    Nat Rev Drug Discov; 2010 Feb; 9(2):141-53. PubMed ID: 20118962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokines in the vascular inflammatory response of atherosclerosis.
    Zernecke A; Weber C
    Cardiovasc Res; 2010 May; 86(2):192-201. PubMed ID: 20007309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney diseases and chemokines.
    Panzer U; Steinmetz OM; Stahl RA; Wolf G
    Curr Drug Targets; 2006 Jan; 7(1):65-80. PubMed ID: 16454700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory therapeutic approaches to reduce acute atherosclerotic complications.
    Kanzler I; Liehn EA; Koenen RR; Weber C
    Curr Pharm Biotechnol; 2012 Jan; 13(1):37-45. PubMed ID: 21470163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerosis as an inflammatory disease.
    Tuttolomondo A; Di Raimondo D; Pecoraro R; Arnao V; Pinto A; Licata G
    Curr Pharm Des; 2012; 18(28):4266-88. PubMed ID: 22390643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manipulating the chemokine system: therapeutic perspectives for atherosclerosis.
    Koenen RR; Weber C
    Curr Opin Investig Drugs; 2010 Mar; 11(3):265-72. PubMed ID: 20178039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets.
    Ramji DP; Davies TS
    Cytokine Growth Factor Rev; 2015 Dec; 26(6):673-85. PubMed ID: 26005197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokines as Therapeutic Targets in Cardiovascular Disease.
    Noels H; Weber C; Koenen RR
    Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):583-592. PubMed ID: 30760014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokines and their receptors in Atherosclerosis.
    van der Vorst EP; Döring Y; Weber C
    J Mol Med (Berl); 2015 Sep; 93(9):963-71. PubMed ID: 26175090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.